Northstar Ventures led the £1.2m round to support the commercial rollout of the medtech firm's diagnostic device.
Funding Announcements
Filter
Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 1 August 2026.
Announcements
5,263
Total raised
£158B
disclosed amounts
£1.2M
£14.6M
The financing will support international expansion and development of the Deltaflow operating system.
"For a quantum ecosystem to thrive, we urgently need an operating system. An operating system makes quantum computers useful – it allows programs and applications to run on many different machines. Riverlane aims to make our operating system Deltaflow a global standard."
Draper Esprit + 3 others
£900K
The London startup secured £900k from backers including Ecclesiastical and Lord Michael Spencer to expand its cashless donation platform.
"We are very excited to be unlocking digital donations so these charities can continue to make hugely positive contributions to society."
£2.5M
Foresight backed the Worcestershire cybersecurity software provider with growth capital to scale operations.
"Titania’s mission is to increase our customers’ network resilience and security compliance, and Foresight’s backing and investment will accelerate our ambitious plans to automatically detect and remediate mis-configurations and vulnerabilities at scale and reduce customers’ attacks while evidencing compliance. Delivering this at scale is especially important in a world in which organisations need to move from occasional auditing through to continuous monitoring of network security. Foresight will support us in achieving our goals, enabling our customers and partners to use Titania as a cornerstone solution in the global Vulnerability Managed Detection and Response technology stack and market."
£2.5M
Sano Genetics raises £2.5m in seed funding led by Episode1 to expand clinical trial recruitment technology
The seed round was led by Episode1 with backing from Seedcamp, Cambridge Enterprise, and January Ventures to fund DNA testing kits and platform development.
"We urgently need more people contributing to medical science, but the gap between those wanting to take part and actually knowing how to is huge. The scientific community has long relied on time-starved doctors signposting patients to clinical trials which just isn’t an effective way to get decent levels of participation. The pandemic has added further challenges, as many patients with rare and chronic diseases are unable to safely leave home."


